Cataract in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD)

Ophthalmic Genetics

Volumn 24, Issue 1, 2003, Pages 49-57

  Russell Eggitt, Isabelle M ^a   Leonard, J V ^b   Lund, A M ^b,c   Manoj, B ^a   Thompson, D A ^a   Morris, A A M ^b  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c Rigshospitalet   (Denmark)

Author keywords

Cataract; LCHAD; Peroxisome; Retinopathy

Indexed keywords

3 HYDROXYACYL COENZYME A DEHYDROGENASE;

ADOLESCENT; ARTICLE; CASE REPORT; CATARACT; DISEASE SEVERITY; ENZYME DEFICIENCY; EYE DISEASE; FEMALE; HUMAN; LONG CHAIN 3 HYDROXYACYL COENZYME A DEHYDROGENASE DEFICIENCY; METABOLIC DISORDER; MORPHOLOGY; PERIPHERAL NEUROPATHY; PEROXISOME; PRIORITY JOURNAL;

3-HYDROXYACYL COA DEHYDROGENASES; ADOLESCENT; CATARACT; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; PEROXISOMAL DISORDERS;

EID: 0037352370     PISSN: 13816810     EISSN: None     Source Type: Journal    
DOI: 10.1076/opge.24.1.49.13890     Document Type: Article

References (26)

1. Folz SJ, Trobe JD. The peroxisome and the eye (review). Surv Ophthalmol. 1991;35(5):353-368.
2. Bertini E, Dionisi-Vici C, Garavaglia B, Burlina AB, Sabatelli M, Rimoldi M, Bartuli A, Sabetta G, DiDonato S. Peripheral sensory-motor polyneuropathy, pigmentary retinopathy, and fatal cardiomyopathy in long-chain 3-hydroxy-acyl-CoA dehydrogenase deficiency. Eur J Pediatr. 1992;151(2):121-126.
3. IJlst L, Uskikubo S, Kamijo T, Hashimoto T, Ruiter JP, de Klerk JB, Wanders RJ. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: High frequency of the G1528C mutation with no apparent correlation with the clinical phenotype. J Inherit Metab Dis. 1995;18(2):241-244.
4. Przyrembel H, Jakobs C, IJlst L, de Klerk JB, Wanders RJ. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. J Inherit Metab Dis. 1991;14(5):674-680.
5. Pons R, Roig M, Riudor E, Ribes A, Briones P, Ortigosa L, Baldellou A, Gil-Gibernau J, Olesti M, Navarro C, Wanders RJ. The clinical spectrum of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Pediatr Neurol. 1996;14(3):236-243.
6. Tyni T, Palotie A, Viinikka L, Valanne L, Salo MK, von Dobeln U, Jackson S, Wanders R, Venizelos N, Pihko H. Long-chain 3-hydroxyacylcoenzyme A dehydrogenase deficiency with the G1528C mutation: clinical presentation of thirteen patients [see comments]. J Pediatr. 1997;130(1):67-76.
7. Tyni T, Kivela T, Lappi M, Summanen P, Nikoskelainen E, Pihko H. Ophthalmologic findings in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency caused by the G1528C mutation: A new type of hereditary metabolic chorioretinopathy. Ophthalmology. 1998;105(5):810-824.
8. Wanders RJ, Duran M, IJlst L, De Jager JP, Van Gennip AH, Jakobs C, Dorland L, Van Sprang FJ. Sudden infant death and long-chain 3-hydroxyacyl-CoA dehydrogenase [letter]. Lancet. 1989;2(8653):52-53.
9. IJlst L, Ruiter JP, Hoovers JM, Jakobs ME, Wanders RJ. Common missense mutation G1528C in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Characterization and expression of the mutant protein, mutation analysis on genomic DNA and chromosomal localization of the mitochondrial trifunctional protein alpha subunit gene. J Clin Invest. 1996;98(4):1028-1033.
10. Jackson S, Bartlett K, Land J, Moxon ER, Pollitt RJ, Leonard JV, Turnbull DM. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Pediatr Res. 1991;29(4 Pt 1):406-411.
11. Moore R, Glasgow JF, Bingham MA, Dodge JA, Pollitt RJ, Olpin SE, Middleton B, Carpenter K. Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency: diagnosis, plasma carnitine fractions and management in a further patient. Eur J Pediatr. 1993;152(5):433-436.
12. Tyni T, Pihko H. Long-chain 3-hydroxy-CoA dehydrogenase deficiency. Acta Pcediatr. 1999;88:237-245.
13. Vici CD, Burlina AB, Bertini E, Bachmann C, Mazziotta MR, Zacchello F, Sabetta G, Hale DE. Progressive neuropathy and recurrent myoglobinuria in a child with long-chain 3-hydroxyacylcoenzyme A dehydrogenase deficiency. J Pediatr. 1991;118(5):744-746.
14. Morris AA, Clayton PT, Surtees RA, Leonard JV. Clinical outcomes in long-chain 3-hydroxyacylcoenzyme A dehydrogenase deficiency [letter; comment]. J Pediatr. 1997;131(6):938.
15. Gillingham MB, van Calcar SC, Ney D, Wolff J, Harding C. Dietary management of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD). A case report and survey. J Inherit Metab Dis. 1999;22:123-131.
16. Tein I, Vajsar J, MacMillan L, Sherwood WG. Long-chain L-3-hydroxyacyl-coenzyme A dehydrogenase deficiency neuropathy: Response to cod liver oil. Neurology. 1999;52:640-643.
17. Glasgow AM, Engel AG, Bier DM, et al. Hypoglycemia, hepatic dysfunction, muscle weakness, cardiomyopathy, free carnitine deficiency and long-chain acylcarnitine excess responsive to medium-chain triglyceride diet. Pediatr Res. 1983;17:319-326.
18. Duran M, Wanders RJ, De Jager JP, Dorland L, Bruinvis L, Ketting D, IJlst L, Van Sprang FJ. 3-Hydroxydicarboxylic aciduria due to long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency associated with sudden neonatal death: Protective effect of medium-chain triglyceride treatment. Eur J Pediatr. 1991;150(3):190-195.
19. Harding CO, Gillingham MB, Van Calcar SC, Wolff JA, Verhoeve JN, Mills MD. Docosahexaenoic acid and retinal function in children with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. J Inherit Metab Dis. 1999;22:276-280.
20. Hagenfeldt L, Venizelos N, Von Dobeln U. Clinical and biochemical presentation of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. J Inherit Metab Dis. 1995;18(2):245-248.
21. Corr PB, Creer MH, Yamada KA, Saffitz JE, Sobel BE. Prophylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation. J Clin Invest. 1989;83:927-936.
22. Tyni T, Pihko H, Kivela T. Ophthalmic pathology in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency caused by the G1528C mutation. Curr Eye Res. 1998;17(6):551-559.
23. Neuringer M, Connor WE, Lin DS, Barstad L, Luck S. Biochemical and functional effects of prenatal and postnatal omega 3 fatty acid deficiency on retina and brain in rhesus monkeys. Proc Natl Acad Sci USA. 1986;83:4021-4025.
24. Birch EE, Birch D, Uauy R. Visual function and essentiality of α-linolenic acid and docosahexaenoic acid in human infants. In: Yehuda S. et al., editors. Handbook of essential fatty acid biology: Biochemistry, physiology and behavioral neurobiology. Totowa, NJ: Humana Press, 1997;1831-199.
25. Birch EE, Garfield S, Hoffman DR, Uauy R, Birch DE. A randomized controlled trial of early dietary supply of long-chain polyunsaturated fatty acids and mental development in term infants. Dev Med Child Neurol. 2000;42(3):174-181.
26. Hittner HM, Kretzer FL, Mehta RS. Zellweger syndrome. Lenticular opacities indicating carrier status and lens abnormalities characteristic of homozygotes. Arch Ophthalmol. 1981;99:1977-1982.